Ken Griffin Ac Immune Sa Put Options Transaction History

Citadel Advisors LLC

  • $509 Billion
  • Q1 2024

Put Options

6 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q1 2024

May 15, 2024
BUY
$2.66 - $4.87 $73,416 - $134,412
27,600 Added 613.33%
32,100 $95,000
Q4 2023

Feb 14, 2024
BUY
$2.46 - $5.0 $10,824 - $22,000
4,400 Added 4400.0%
4,500 $22,000
Q3 2023

Nov 14, 2023
SELL
$2.77 - $3.38 $5,540 - $6,760
-2,000 Reduced 95.24%
100 $0
Q2 2023

Aug 14, 2023
BUY
$1.85 - $3.4 $2,590 - $4,760
1,400 Added 200.0%
2,100 $6,000
Q1 2023

May 15, 2023
SELL
$2.13 - $2.49 $12,354 - $14,442
-5,800 Reduced 89.23%
700 $1,000
Q4 2022

Feb 14, 2023
BUY
$1.72 - $3.12 $11,180 - $20,280
6,500 New
6,500 $13,000

Others Institutions Holding ACIU

# of Institutions
41
Shares Held
29M
Call Options Held
92.9K
Put Options Held
46.3K
View Full List

About AC Immune SA

ACIU Quotes by TradingView
  • Ticker ACIU
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 83,413,504
  • Market Cap $333M
  • Description
  • AC Immune SA, a clinical stage biopharmaceutical company, discovers, designs, and develops medicines and diagnostic products for the prevention and treatment of neurodegenerative diseases associated with protein misfolding. Its SupraAntigen and Morphomer platforms are designed to generate vaccines, antibodies, and small molecules, which selectiv...
More about ACIU
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email